We observed that the tested solid tumor cells were substantially less sensitive to the Cpd_DC60 treatment (blue; IC50 > 50 μM) as compared to the MLL-r leukemia cells (red; IC50: 5.7 to 16.0 μM). The gene discussed is KMT2A; the disease is leukemia.